Engineered BioPharmaceuticals Revenue and Competitors

Engineered BioPharmaceuticals, Inc. is a state-of-the-art biotechnology company focused on advancing dry powder pharmaceutical manufacturing and delivery through Atmospheric Spray Freeze Drying (ASFD) technology. Manufacturing dry powder pharmaceuticals using the ASFD process offers many possibilities including increased stability and shelf life of drug formulations, ability to store at room temperature, reduced weight and bulk, and the ability to facilitate the development of novel self-administration methods of delivery, such as nasal and pulmonary. A significant advantage of the ASFD process compared to its competitors is that it allows pharmaceutical powders to be “engineered” for a wide variety of final use applications. A specific final particle size is easily achieved by adjusting the droplet diameter via the spray nozzle. In addition, the density, and thereby the aerodynamic size, can be adjusted independent of the geometric diameter by altering the starting solute concentration. With our population demanding sophisticated therapeutics to extend life expectancy and improve quality of life, contrasted with the dire need to reduce spiraling healthcare costs, there is enormous pressure and opportunity for the pharmaceutical industry to embrace new technologies that answer the call. We are excited about the innovative work taking place at eBio to advance the field and look forward to the opportunity to use ASFD technology to impact the future of medicine.